| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Oct―13 |
Neurological Adverse Events from COVID-19 Vaccination and It’s Associated Factors in Burkina Faso: Analysis of Spontaneous Reports from the National Database of Pharmacovigilance from 2021 to 2023 |
Alfred Anselme Dabilgou, Emile Wendni Ouedraogo, Julie Marie Adeline Wendlamita Kyelem, Alassane Dravé, Ousmane Wanré, Christain Napon, Athanase Millogo |
| 2 |
[GO] |
2025―Oct―10 |
Cytokine Blockade Attenuates Inflammation and Improves Depressive Psychopathology After COVID-19: A Naturalistic Observational Study |
Mariagrazia Palladini, Alessia A. Azzalin, Margherita Bessi, Rebecca De Lorenzo, Patrizia Rovere-Querini, Francesco Benedetti, Mario Gennaro Mazza |
| 3 |
[GO] |
2025―May―22 |
COVID-19 Alters Inflammatory, Mitochondrial, and Protein Clearance Pathway Genes: Potential Implications for New-onset Parkinsonism in Patients |
Chukwunonso K. Nwabufo |
| 4 |
[GO] |
2024―May―21 |
Differential Cytokine Responses of APOE3 and APOE4 Blood-brain Barrier Cell Types to SARS-CoV-2 Spike Proteins |
Juliana C. S. Chaves, Laura A. Milton, Romal Stewart, Tarosi Senapati, Laura M. Rantanen, Joanna M. Wasielewska, et al. (+8) Serine Lee, Damián Hernández, Lachlan McInnes, Hazel Quek, Alice Pébay, Paul S. Donnelly, Anthony R. White, Lotta E. Oikari |
| 5 |
[GO] |
2023―Oct―27 |
Prenatal SARS-CoV-2 Spike Protein Exposure Induces Autism-Like Neurobehavioral Changes in Male Neonatal Rats |
Mumin Alper Erdogan, Miray Turk, Gizem Dinler Doganay, Ibrahim Halil Sever, Bahattin Ozkul, Ibrahim Sogut, et al. (+3) Ebru Eroglu, Yigit Uyanikgil, Oytun Erbas |
| 6 |
[GO] |
2023―Mar―26 |
CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study |
Martin K. R. Svačina, Anika Meißner, Finja Schweitzer, Alina Sprenger-Svačina, Ines Klein, Hauke Wüstenberg, et al. (+4) Felix Kohle, Helene L. Walter, Michael Schroeter, Helmar C. Lehmann |
| 7 |
[GO] |
2021―Dec―22 |
The Neuroimmune Pharmacology of SARS-CoV-2 |
Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack, Gurudutt Pendyala, Sanjay Maggirwar, Sulie L. Chang |
| 8 |
[GO] |
2021―Dec―11 |
Correction to: Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID |
Erin Clough, Joseph Inigo, Dhyan Chandra, Lee Chaves, Jessica L. Reynolds, Ravikumar Aalinkeel, et al. (+3) Stanley A. Schwartz, Alexander Khmaladze, Supriya D. Mahajan |
| 9 |
[GO] |
2021―Nov―30 |
Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 10 |
[GO] |
2021―Nov―26 |
The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings |
Jean M. Bidlack, Sulie L. Chang, Sylvia Fitting, Howard E. Gendelman, Santhi Gorantla, Santosh Kumar, et al. (+5) Maria Cecilia Garibaldi Marcondes, Douglas D. Meigs, Loyda M. Melendez, Ilker K. Sariyer, Sowmya Yelamanchili |
| 11 |
[GO] |
2021―Nov―10 |
Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection |
Ryan C. Camacho, Sedra Alabed, Heping Zhou, Sulie L. Chang |
| 12 |
[GO] |
2021―Oct―23 |
SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation |
Brandon J. DeOre, Kiet A. Tran, Allison M. Andrews, Servio H. Ramirez, Peter A. Galie |
| 13 |
[GO] |
2021―Oct―22 |
Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses |
Ramesh Kumar Paidi, Malabendu Jana, Sumita Raha, Mary McKay, Monica Sheinin, Rama K. Mishra, Kalipada Pahan |
| 14 |
[GO] |
2021―Oct―16 |
Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications |
Jag H. Khalsa, Sanjay B. Maggirwar, Greg Bunt |
| 15 |
[GO] |
2021―Oct―04 |
Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID |
Erin Clough, Khoo Ting Chean, Joseph Inigo, Kate E. Tubbesing, Dhyan Chandra, Lee Chaves, et al. (+5) Jessica L. Reynolds, Ravikumar Aalinkeel, Stanley A. Schwartz, Alexander Khmaladze, Supriya D. Mahajan |
| 16 |
[GO] |
2021―Sep―09 |
Racial Health Disparity and COVID-19 |
Santosh Kumar, Prashant Kumar, Sunitha Kodidela, Benjamin Duhart, Alina Cernasev, Anantha Nookala, et al. (+3) Asit Kumar, Udai P. Singh, John Bissler |
| 17 |
[GO] |
2021―Aug―24 |
Investigating Neurological Manifestations of SARS-CoV-2 |
Maryam Mozafar, Seyed Amir Mirmotalebisohi, Marzieh Sameni, Hakimeh Zali |
| 18 |
[GO] |
2021―Jun―28 |
Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop |
Santosh Kumar, Gurudutt Pendyala, Sowmya V. Yelamanchili, Pankaj Seth, Sanjay Maggirwar, Jean M. Bidlack, Sulie L. Chang |
| 19 |
[GO] |
2021―May―28 |
The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections |
Kevin Roe |
| 20 |
[GO] |
2021―May―18 |
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals |
Marco Cosentino, Marco Ferrari, Franca Marino |
| 21 |
[GO] |
2021―Feb―05 |
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention |
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, et al. (+21) Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman, Bhavesh D. Kevadiya |
| 22 |
[GO] |
2021―Feb―03 |
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? |
Adriano José Maia Chaves Filho, Franciane Gonçalves, Melina Mottin, Carolina Horta Andrade, Silvia Nunes Szente Fonseca, Danielle S. Macedo |
| 23 |
[GO] |
2021―Jan―18 |
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome |
Júlia Leão Batista Simões, Margarete Dulce Bagatini |
| 24 |
[GO] |
2021―Jan―11 |
ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy |
Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Sumita Raha, Kalipada Pahan |
| 25 |
[GO] |
2021―Jan―06 |
Is COVID-19 Gender-sensitive? |
Shreya Mukherjee, Kalipada Pahan |
| 26 |
[GO] |
2021―Jan―06 |
Pharmacotherapeutics of SARS-CoV-2 Infections |
Bhavesh D. Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D. Oleynikov, Wilson R. Blomberg, Neha Bajwa, et al. (+14) Dhruvkumar Soni, Srijanee Das, Mahmudul Hasan, Milankumar Patel, Ahmed M. Senan, Santhi Gorantla, JoEllyn McMillan, Benson Edagwa, Robert Eisenberg, Channabasavaiah B. Gurumurthy, St Patrick M. Reid, Chamindie Punyadeera, Linda Chang, Howard E. Gendelman |
| 27 |
[GO] |
2021―Jan―06 |
SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation |
Jessica. L. Reynolds, Supriya D. Mahajan |
| 28 |
[GO] |
2021―Jan―04 |
Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? |
Francesco Benedetti, Mario Gennaro Mazza, Giulio Cavalli, Fabio Ciceri, Lorenzo Dagna, Patrizia Rovere-Querini |
| 29 |
[GO] |
2020―Oct―26 |
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? |
Francesco Benedetti, Mario Mazza, Giulio Cavalli, Fabio Ciceri, Lorenzo Dagna, Patrizia Rovere-Querini |
| 30 |
[GO] |
2020―Sep―15 |
Infectivity of SARS-CoV-2: there Is Something More than D614G? |
Saathvik R. Kannan, Austin N. Spratt, Thomas P. Quinn, Xiao Heng, Christian L. Lorson, Anders Sönnerborg, et al. (+2) Siddappa N. Byrareddy, Kamal Singh |
| 31 |
[GO] |
2020―Sep―10 |
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review |
Tejas K. Patel, Manish Barvaliya, Bhavesh D. Kevadiya, Parvati B. Patel, Hira Lal Bhalla |
| 32 |
[GO] |
2020―Sep―10 |
Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review |
Tejas K. Patel, Manish Barvaliya, Bhavesh D. Kevadiya, Parvati B. Patel, Hira Lal Bhalla |
| 33 |
[GO] |
2020―Jul―21 |
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections |
Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, Debashis Dutta, Barnali Nath, Maxim D. Oleynikov, et al. (+9) Wilson R. Blomberg, Douglas D. Meigs, Mahmudul Hasan, Milankumar Patel, Peter Kline, Raymond Chuen-Chung Chang, Linda Chang, Howard E. Gendelman, Bhavesh D. Kevadiya |
| 34 |
[GO] |
2020―Jun―29 |
Clomipramine Could Be Useful in Preventing Neurological Complications of SARS-CoV-2 Infection |
B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet |
| 35 |
[GO] |
2020―Jun―25 |
Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” |
Erkan Cure, Medine Cumhur Cure, Adem Kucuk |
| 36 |
[GO] |
2020―Jun―11 |
May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal |
Yasin Hasan Balcioglu, Umit Haluk Yesilkaya, Hasan Gokcay, Simge Seren Kirlioglu |
| 37 |
[GO] |
2020―May―23 |
SARS-CoV-2 Infection Leads to Neurological Dysfunction |
Arpan Acharya, Bhavesh D. Kevadiya, Howard E. Gendelman, Siddappa N. Byrareddy |
| 38 |
[GO] |
2020―May―15 |
Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? |
Priyanka Pahan, Kalipada Pahan |
| 39 |
[GO] |
2020―May―07 |
Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms |
Roham Mazloom |
|
